Federal Register / Vol. 75, No. 27 / Wednesday, February 10, 2010 / Notices 6673 

knowledge of local, State, and Federal 

housing programs and how they can be 

accessed; or 

ii. Short-term or emergency housing 

defined as necessary to gain or maintain 

access to medical care and must be 

related to either: 

a. Housing services that include some 

type of medical or supportive service: 

including, but not limited to, residential 

substance abuse or mental health 

services (not including facilities 

classified as an Institute of Mental 

Diseases under Medicaid), residential 

foster care, and assisted living 

residential services; or 

b. Housing services that do not 

provide direct medical or supportive 

services, but are essential for an 

individual or family to gain or maintain 

access and compliance with HIV-related 

medical care and treatment. Necessity of 

housing services for purposes of 

medical care must be certified or 

documented. 

B. Short-term or emergency assistance 

is understood as transitional in nature 

and for purposes of moving or 

maintaining an individual or family in 

a long-term, stable living situation. 

Thus, such assistance cannot be 

permanent and must be accompanied by 

a strategy to identify, relocate, and/or 

ensure the individual or family is 

moved to, or capable of maintaining, a 

long-term, stable living situation. 

C. Housing funds cannot be in the 

form of direct cash payments to 

recipients for services and cannot be 

used for mortgage payments. 

D. The Ryan White HIV/AIDS 

Program must be the payer of last resort. 

In addition, funds received under the 

Ryan White HIV/AIDS Program must be 

used to supplement, but not supplant 

funds currently being used from local, 

State, and Federal Agency programs. 

Grantees must be capable of providing 

HAB with documentation related to the 

use of funds as the payer of last resort 

and the coordination of such funds with 

other local, State, and Federal funds. 

E. Housing-related expenses are 

limited to Parts A, B, and D of the Ryan 

White HIV/AIDS Program, and are not 

allowable expenses under Part C. 

Dated: February 5, 2010. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2010–2926 Filed 2–9–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Expert Meeting on Measurement 

Criteria for Children’s Health Insurance 

Program; Reauthorization Act Pediatric 

Quality Measures 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ). 

ACTION: Notice of public meeting. 

SUMMARY: This notice announces a 

meeting to identify measurement 

criteria for use in carrying out the 

Pediatric Quality Measures Program 

(PQMP) under Section 1139A(b) of the 

Social Security Act as enacted in the 

Children’s Health Insurance Program 

Reauthorization Act (CHIPRA). 

DATES: The meeting will be held on 

Wednesday, February 24, 2010, from 10 

a.m. to 5 p.m. and Thursday, February 

25, 2010, from 8 a.m. to 4 p.m. 

ADDRESSES: Agency for Healthcare 

Research and Quality Eisenberg 

Building, 540 Gaither Rd., Rockville, 

MD 20850 and by public webcast. 

FOR FURTHER INFORMATION CONTACT: 

Maushami DeSoto, Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850, (301) 427–1546. For press-related 

information, please contact Karen 

Migdail at (301) 427–1855. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact Mr. 

Michael Chew, Director, Office of Equal 

Employment Opportunity Program, 

Program Support Center, on (301) 443– 

1144, no later than February 20, 2010. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

In early 2009, CHIPRA (Pub. L. 111– 

3) reauthorized the Child Health 

Insurance Program (CHIP) originally 

established in 1997, and in Title IV of 

the law, added a number of new 

provisions designed to improve health 

care quality and outcomes for children. 

AHRQ is working closely with the 

Centers for Medicare and Medicaid 

Services (CMS) and the CHIPRA Federal 

Quality Workgroup in implementing 

these provisions. For more information 

about AHRQ’s role in carrying out the 

quality provisions of CHIPRA, and for a 

list of an initial core set of children’s 

healthcare quality measures voluntary 

use by Medicaid programs and 

Children’s Health Insurance Programs 

and the health plans and providers of 

care that the programs engage with, 

mandated by the Act, that has been 

identified and posted for public 

comment, see http://www.ahrg.gov/ 

chip/chipraact.htm. 

CHIPRA further directed the Secretary 

to establish a Pediatric Quality 

Measures Program (PQMP) to strengthen 

and expand the initial core measure set 

required under its section 401(a). The 

statutory goal of the PQMP is to produce 

an improved core set of children’s 

healthcare quality measures for use by 

public and private programs, health 

insurers, providers and patients, by 

January 1, 2013. In order to achieve this 

goal, measurement criteria to develop 

and enhance pediatric health care 

measures need to be identified and 

framed for use by those who will be 

developing and enhancing the measures 

under the PQMP. The PQMP objectives 

are to: Expand, improve and strengthen 

the initial core measure set and existing 

pediatric measures used by public and 

private health care purchasers and 

advance the development of new and 

emerging quality measures; and thereby, 

increase the portfolio of evidence-based 

and consensus-based, pediatric quality 

measures available to public and private 

purchasers of children’s health care 

services, providers, and consumers as 

well as for use by policymakers at all 

political levels, including use in 

mandated reports to Congress on 

voluntary State reporting and on any 

need for further legislation. 

In accordance with statutory 

requirements, the measures to be 

developed or enhanced under this 

program will cover a range of pediatric 

preventive services, treatments and 

services for both acute and chronic 

conditions, including health services to 

correct or ameliorate the effects of 

physical and mental conditions; and 

health services to aid in the growth and 

development of children with special 

health care needs; and measure and 

duration of health care coverage. Said 

measures are to be designed to ensure 

that data collected are comparable at the 

State, health plan and provider levels, 

risk-adjusted if appropriate, and 

periodically updated. In addition, 

pursuant to section 401(s) of CHIPRA, 

measures are to be able to identify 

disparities by race and ethnicity, 

socioeconomic status, and special 

healthcare needs. 

II. Agenda 

On Wednesday, February 24, 2010, 

the meeting will convene at 10 a.m. The 

meeting will focus on engaging invited 

experts and public participants in 

identifying criteria for pediatric quality 

measures to be used by PQMP grant and 

contract program awardees beginning in 

September 2010. The agenda will cover 


sroberts on DSKD5P82C1PROD with NOTICES
6674 Federal Register / Vol. 75, No. 27 / Wednesday, February 10, 2010 / Notices 

discussions of key measure criteria in 

existence and participants will be asked 

to identify criteria suitable for the 

measure development and enhancement 

work to be supported by the PQMP 

program. 

A more specific proposed agenda and 

instructions for public access to the 

meeting will be posted before the 

meeting at http://www.ahrg.gov/chip/ 

chipraact.htm. The final agenda, 

including the time for public comment 

during the meeting, will be available on 

the AHRQ Web site at http:// 

www.ahrg.gov/chip/chipraact.htm no 

later than February 14, 2010. A 

transcript of the meeting will be 

available within 21 business days after 

the meeting. 

Dated: February 2, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–2873 Filed 2–9–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

February 25, 2010, 1 p.m. to February 

25, 2010, 4 p.m., National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD, 20892 which was published in the 

Federal Register on February 1, 2010, 

75 FR 5092. 

The meeting will be held February 22, 

2010, from 11 a.m. to 2 p.m. The 

meeting location remains the same. 

The meeting is closed to the public. 

Dated: February 2, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–2886 Filed 2–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Auditory, Pain and 

Chemosensation. 

Date: March 1–2, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Lynn E. Luethke, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5166, 

MSC 7844, Bethesda, MD 20892, (301) 806– 

3323, luethkel@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Drug Discovery and Development. 

Date: March 1–2, 2010. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sergei Ruvinov, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892. 301–435– 

1180. ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Microvascular Interactions. 

Date: March 3, 2010. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Manjit Hanspal, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1195, hanspalm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Fellowship: 

Chemical and Bioanalytical Sciences. 

Date: March 4, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Denise Beusen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1267, beusend@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Topics in Cancer Research. 

Date: March 8–9, 2010. 

Time: 10 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Eun Ah Cho, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Bethesda, MD 20892, (301) 451– 

4467, choe@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Program 

Project: National Radiotracer Resource 

Center. 

Date: March 14–16, 2010. 

Time: 6 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Parkway Hotel, 4550 Forest 

Park Avenue, St. Louis, MO 63108. 

Contact Person: Keith Crutcher, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5207, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1278, crutcherka@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, 

Behavioral and Social Consequences of HIV/ 

AIDS Study Section. 

Date: March 15–16, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Marriott, 4100 

Admiralty Way, Marina del Rey, CA 90292. 

Contact Person: Mark P. Rubert, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–806– 

6596, rubertm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR Panel: 

Cancer Health Disparities. 

Date: March 15–16, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco, 700 F Street, NW., 

Washington, DC 20001. 

Contact Person: Nywana Sizemore, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6204, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1718, sizemoren@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: CDIN and CNN Member 

Applications II. 

Date: March 15, 2010. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 


sroberts on DSKD5P82C1PROD with NOTICES